stage iiic ovarian cancer
Showing 1 - 21 of 21
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial in Seattle (drug,
Terminated
- Stage III Fallopian Tube Cancer
- +14 more
- Carboplatin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 17, 2021
Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)
Completed
- Fallopian Tube Carcinoma
- +14 more
- Diagnostic Microscopy
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 5, 2021
Stage IIIC Ovarian Cancer Trial in Rome (Neoadjuvant chemo + Interval Debulking Surgery, Primary Debulking Surgery + Adjuvant
Completed
- Stage IIIC Ovarian Cancer
- Neoadjuvant chemotherapy + Interval Debulking Surgery
- Primary Debulking Surgery + Adjuvant Chemotherapy
-
Rome, ItalyCatholic University of the Sacred Heart
Oct 10, 2020
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Completed
- Fallopian Tube Clear Cell Adenocarcinoma
- +26 more
- Bevacizumab
- +5 more
-
Anniston, Alabama
- +631 more
Jul 19, 2019
Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory
Completed
- Advanced Malignant Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, Arizona
- +1 more
Jun 5, 2019
Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,
Completed
- Adult Hepatocellular Carcinoma
- +44 more
- Bevacizumab
- Temsirolimus
-
Scottsdale, Arizona
- +60 more
Jan 24, 2019
Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Cancer, Stage IIIA Primary Peritoneal Cancer Trial (drug, procedure, other)
Withdrawn
- Stage IIIA Fallopian Tube Cancer
- +11 more
- (S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid (18F-FSPG)
- +2 more
- (no location specified)
Jun 4, 2018
Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma Trial in Hinsdale, Providence (procedure,
Terminated
- Nausea and Vomiting
- +26 more
- Adjuvant Therapy
- +7 more
-
Hinsdale, Illinois
- +1 more
Apr 24, 2018
YKL-40 in Serum Samples From Newly Diagnosed Stage III-IV
Terminated
- Fallopian Tube Adenocarcinoma
- +29 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Mobile, Alabama
- +130 more
May 21, 2018
Stage I Breast Cancer, Stage I Cervical Cancer, Stage I Ovarian Cancer Trial in Philadelphia, Reading (Informational
Completed
- Stage I Breast Cancer
- +38 more
- Informational Intervention
-
Philadelphia, Pennsylvania
- +1 more
Feb 20, 2018
Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer Trial in United States (Laboratory
Completed
- Stage IA Fallopian Tube Cancer
- +23 more
- Laboratory Biomarker Analysis
- +2 more
-
Mobile, Alabama
- +45 more
Sep 12, 2017
Tumor Tissue Samples From Undergone Surgery for Advanced Stage
Recruiting
- Stage IIIA Ovarian Cancer
- +3 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 2, 2017
Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,
Withdrawn
- Estrogen Receptor Negative
- +22 more
- Laboratory Biomarker Analysis
- +2 more
- (no location specified)
Apr 20, 2017
Caregiver, Stage IIIA Ovarian Cancer, Stage IIIB Ovarian Cancer Trial in Seattle (Telephone-Based Intervention,
Completed
- Caregiver
- +4 more
- Telephone-Based Intervention
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Mar 6, 2017
Chemotherapeutic Agent Toxicity, Neuropathy, Neurotoxicity Syndrome Trial in United States (Carboplatin, Glutathione, Laboratory
Completed
- Chemotherapeutic Agent Toxicity
- +15 more
- Carboplatin
- +5 more
-
Mobile, Alabama
- +389 more
Jan 5, 2017
Collecting Tumor Samples From Patients With Gynecological Tumors
Completed
- Borderline Ovarian Clear Cell Tumor
- +85 more
- Laboratory Biomarker Analysis
-
Fayetteville, Arkansas
- +186 more
Oct 26, 2016
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)
Completed
- Anaplastic Astrocytoma
- +64 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2016
Malignant Ovarian Clear Cell Tumor, Malignant Ovarian Serous Tumor, Recurrent Fallopian Tube Carcinoma Trial (Aldesleukin,
Withdrawn
- Malignant Ovarian Clear Cell Tumor
- +16 more
- Aldesleukin
- +3 more
- (no location specified)
Feb 15, 2016
Patients With Advanced Ovarian Epithelial Cancer
Withdrawn
- Ovarian Serous Cystadenocarcinoma
- +5 more
- Comparative Genomic Hybridization
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 29, 2015